Literature DB >> 18579640

Fidelity and evolution of recurrent FSGS in renal allografts.

Daphne H T IJpelaar1, Alton B Farris, Natascha Goemaere, Kerstin Amann, Roel Goldschmeding, Tri Q Nguyen, Evan Farkash, Marius C van den Heuvel, Emile de Heer, Jan A Bruijn, Robert B Colvin, Ingeborg M Bajema.   

Abstract

Five pathologic variants of FSGS were recently defined ("Columbia classification"), but the stability of these phenotypes in renal allografts remains unknown. We hypothesized that if the variants represent distinct diseases, then the pattern of recurrent FSGS in renal allografts will mimic the original disease in the native kidney. This multicenter study included 21 cases of recurrent FSGS from 19 patients who had both native and transplant biopsy samples available for analysis. These results support the Columbia classification, because 81% recurred in the same pattern as the original disease, but three variants manifested plasticity from native to allograft kidneys or in the pattern of recurrence (four FSGS, not otherwise specified [NOS] to collapsing variant, two collapsing variant to FSGS NOS, and one cellular variant to FSGS NOS). No transitions between the cellular and the collapsing variants were observed, supporting the view that these are separate entities. Three categories of recurrence were observed: Type I, recurrence of the same variant of FSGS; type II, recurrence of the same FSGS variant, preceded by a minimal change-like lesion; and type III, recurrence of a different FSGS variant in the allograft. Thus, potential evolution of the pathologic phenotype should be considered in pathologic interpretation and clinical trials.

Entities:  

Mesh:

Year:  2008        PMID: 18579640      PMCID: PMC2573002          DOI: 10.1681/ASN.2007121365

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  18 in total

1.  Renal biopsy.

Authors:  M P Madaio
Journal:  Kidney Int       Date:  1990-09       Impact factor: 10.612

Review 2.  The many masks of focal segmental glomerulosclerosis.

Authors:  V D'Agati
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

3.  Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis.

Authors:  A Fogo; E P Hawkins; P L Berry; A D Glick; M L Chiang; R C MacDonell; I Ichikawa
Journal:  Kidney Int       Date:  1990-07       Impact factor: 10.612

4.  Focal segmental glomerulosclerosis: prognostic implications of the cellular lesion.

Authors:  M M Schwartz; J Evans; R Bain; S M Korbet
Journal:  J Am Soc Nephrol       Date:  1999-09       Impact factor: 10.121

5.  Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy.

Authors:  A Moudgil; C C Nast; A Bagga; L Wei; A Nurmamet; A H Cohen; S C Jordan; M Toyoda
Journal:  Kidney Int       Date:  2001-06       Impact factor: 10.612

6.  Idiopathic collapsing focal segmental glomerulosclerosis: a clinicopathologic study.

Authors:  A Valeri; L Barisoni; G B Appel; R Seigle; V D'Agati
Journal:  Kidney Int       Date:  1996-11       Impact factor: 10.612

7.  Changes at the glomerular tip: a feature of membranous nephropathy and other disorders associated with proteinuria.

Authors:  A J Howie
Journal:  J Pathol       Date:  1986-09       Impact factor: 7.996

8.  Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.

Authors:  Micky J Chun; Stephen M Korbet; Melvin M Schwartz; Edmund J Lewis
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

9.  Zonal distribution of glomerular collapse in renal allografts: possible role of vascular changes.

Authors:  Tibor Nadasdy; Carol Allen; Martin S Zand
Journal:  Hum Pathol       Date:  2002-04       Impact factor: 3.466

10.  The importance of sample size in the interpretation of the renal biopsy.

Authors:  H L Corwin; M M Schwartz; E J Lewis
Journal:  Am J Nephrol       Date:  1988       Impact factor: 3.754

View more
  18 in total

1.  Focal segmental glomerulosclerosis in renal allografts: Is it possible to diagnose the etiology?

Authors:  S Radha; T Afroz; Ch R Prasad; G Sridhar; K G Rajaram; S Reddy
Journal:  Indian J Nephrol       Date:  2015 Mar-Apr

2.  Nephrotic Syndrome Post-Kidney Transplant.

Authors:  Randolph A Hennigar; Christina L Klein
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-08       Impact factor: 8.237

3.  A study of interobserver reproducibility of morphologic lesions of focal segmental glomerulosclerosis.

Authors:  Shane M Meehan; Anthony Chang; Ian W Gibson; Lisa Kim; Neeraja Kambham; Zoltan Laszik
Journal:  Virchows Arch       Date:  2012-12-21       Impact factor: 4.064

Review 4.  Minimal change disease and idiopathic FSGS: manifestations of the same disease.

Authors:  Rutger J Maas; Jeroen K Deegens; Bart Smeets; Marcus J Moeller; Jack F Wetzels
Journal:  Nat Rev Nephrol       Date:  2016-10-17       Impact factor: 28.314

5.  A patient with nephrotic-range proteinuria and focal global glomerulosclerosis.

Authors:  Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2013-07-25       Impact factor: 8.237

Review 6.  Causes and pathogenesis of focal segmental glomerulosclerosis.

Authors:  Agnes B Fogo
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

Review 7.  [Kidney transplant pathology].

Authors:  K Amann; M Büttner; K Benz; H Schöcklmann
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

Review 8.  Current status of pediatric renal transplant pathology.

Authors:  Jan U Becker
Journal:  Pediatr Nephrol       Date:  2016-05-24       Impact factor: 3.714

9.  Dystroglycan in the diagnosis of FSGS.

Authors:  Giovanna Giannico; Haichun Yang; Eric G Neilson; Agnes B Fogo
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-24       Impact factor: 8.237

10.  Podocyte effacement closely links to suPAR levels at time of posttransplantation focal segmental glomerulosclerosis occurrence and improves with therapy.

Authors:  Nada Alachkar; Changli Wei; Lois J Arend; Annette M Jackson; Lorraine C Racusen; Alessia Fornoni; George Burke; Hamid Rabb; Kavita Kakkad; Jochen Reiser; Michelle M Estrella
Journal:  Transplantation       Date:  2013-10-15       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.